Ceredex Value Advisors LLC Lowers Stock Position in The Allstate Co. (NYSE:ALL)

Ceredex Value Advisors LLC lowered its holdings in shares of The Allstate Co. (NYSE:ALL) by 48.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 148,700 shares of the insurance provider’s stock after selling 138,250 shares during the period. Ceredex Value Advisors LLC owned approximately 0.06% of Allstate worth $28,338,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Northwest Investment Counselors LLC bought a new stake in shares of Allstate in the 3rd quarter worth $28,000. Versant Capital Management Inc boosted its holdings in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares during the last quarter. Family Firm Inc. purchased a new position in shares of Allstate in the 2nd quarter worth $38,000. MCF Advisors LLC boosted its position in Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares during the last quarter. Finally, First Command Advisory Services Inc. bought a new stake in Allstate during the second quarter valued at approximately $58,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling

In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares of the company’s stock, valued at $5,236,922.32. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Robert Toohey sold 16,682 shares of the company’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $180.17, for a total transaction of $3,005,595.94. Following the completion of the sale, the executive vice president now directly owns 4,873 shares of the company’s stock, valued at $877,968.41. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 192,530 shares of company stock worth $34,967,665. 1.80% of the stock is owned by insiders.

Allstate Stock Performance

Shares of NYSE ALL opened at $184.18 on Friday. The Allstate Co. has a 1 year low of $127.93 and a 1 year high of $198.79. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. The company’s fifty day moving average price is $188.87 and its 200 day moving average price is $175.16. The company has a market capitalization of $48.63 billion, a PE ratio of 11.93, a price-to-earnings-growth ratio of 1.91 and a beta of 0.48.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, beating the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a return on equity of 27.74% and a net margin of 6.77%. Allstate’s revenue for the quarter was up 14.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.81 EPS. On average, research analysts predict that The Allstate Co. will post 14.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ALL has been the subject of several recent research reports. Piper Sandler boosted their price target on Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a report on Friday, August 16th. Wells Fargo & Company cut their price objective on Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a research note on Friday, August 16th. Bank of America raised their target price on shares of Allstate from $216.00 to $233.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. The Goldman Sachs Group raised their price objective on shares of Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research report on Thursday, August 15th. Finally, StockNews.com downgraded shares of Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. One investment analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $207.19.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.